Neuroprotection after cardiac arrest with 2-iminobiotin: a single center phase IIa study on safety, tolerability, and pharmacokinetics

por Admiraal, M. M., Velseboer, D. C., Tjabbes, H., Vis, P., Peeters-Scholte, C., Horn, J.
Publicado 2023